Sleep is a vital function of the human body, and a lack of sleep can have serious implications on physical and mental health. For those who suffer from chronic insomnia, the search for a safe and effective sleep aid can be a frustrating one. Hydroxyzine, an antihistamine used to treat allergies and anxiety, is increasingly being used as an off-label treatment for insomnia. In this article, we will examine the potential benefits of hydroxyzine for sleep, as well as the optimal dosage for maximal effectiveness.
Hydroxyzine is an antihistamine used to treat symptoms of allergies and anxiety. It is available in both oral and injectable forms, and is sold under various brand names, including Atarax, Vistaril, and Anxanil. Hydroxyzine works by blocking histamine receptors, which helps to reduce inflammation and anxiety. It is also known to have sedative effects, which makes it an attractive option for those seeking relief from insomnia.
Hydroxyzine has been shown to be effective in treating insomnia in both short-term and long-term studies. In a double-blind, placebo-controlled study of patients with chronic insomnia, hydroxyzine was found to be more effective than a placebo in improving sleep quality and duration. In another study, hydroxyzine was found to be more effective than diphenhydramine, another antihistamine, in improving sleep quality and reducing daytime sleepiness. Hydroxyzine also has the advantage of being less likely to cause next-day drowsiness than other sleep aids. This is due to its long half-life, which means that it remains active in the body for a longer period of time. This makes it an attractive option for those who need to be able to function during the day.
The optimal dosage of hydroxyzine for sleep will vary depending on the individual. Generally, the recommended dosage is 25-50 mg taken at bedtime. However, some individuals may need higher doses, up to 100 mg per night. It is important to note that hydroxyzine should not be taken for more than two weeks at a time, as it can lead to tolerance and dependence.
Hydroxyzine is generally well-tolerated, but it can cause some side effects, including dry mouth, drowsiness, dizziness, and constipation. It can also interact with other medications, so it is important to discuss any potential interactions with your doctor before taking hydroxyzine.
Hydroxyzine is an effective and safe option for those looking for relief from insomnia. It is generally well-tolerated and less likely to cause next-day drowsiness than other sleep aids. The optimal dosage will vary depending on the individual, but is generally 25-50 mg taken at bedtime. It is important to speak to your doctor before taking hydroxyzine, as it can interact with other medications and can cause side effects.
1.
Belgian Algorithm Reshapes Endometrial Cancer Care
2.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Consensus Recommendations for Healthy Hematologic Aging
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation